ANZEMET is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Validus Pharmaceuticals Llc. The primary component is Dolasetron Mesylate.
| Product ID | 30698-220_3b3a8574-591c-46b7-99cc-adca27a22c01 |
| NDC | 30698-220 |
| Product Type | Human Prescription Drug |
| Proprietary Name | ANZEMET |
| Generic Name | Dolasetron Mesylate |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 1997-09-11 |
| Marketing Category | NDA / |
| Application Number | NDA020623 |
| Labeler Name | Validus Pharmaceuticals LLC |
| Substance Name | DOLASETRON MESYLATE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Serotonin 3 Receptor Antagonists [MoA],Serotonin-3 Receptor Antagonist [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2022-12-31 |
| Marketing Start Date | 1997-09-11 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 30698-120 | ANZEMET | dolasetron mesylate |
| 30698-121 | ANZEMET | dolasetron mesylate |
| 30698-220 | ANZEMET | dolasetron mesylate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() ANZEMET 74343289 1863035 Live/Registered |
U.S. PHARMACEUTICALS HOLDINGS II, LLC 1992-12-28 |